Report cover image

Chronic Pancreatitis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published Dec 05, 2025
SKU # BIS20635506

Description

Market Overview

The global chronic pancreatitis market is primarily driven by therapies aimed at managing exocrine pancreatic insufficiency (EPI) and symptomatic pain control, as no disease-modifying drug has yet been approved. Market expansion is supported by increasing chronic pancreatitis prevalence, improved diagnostic rates, and the growing burden of diabetes linked to chronic pancreatitis. However, lack of curative options, reliance on supportive therapy, and high treatment costs remain constraints.

Impact

Increasing demand for chronic pancreatitis therapies is anticipated to support the growth of the global chronic pancreatitis market during the forecast period 2025-2035.
The global chronic pancreatitis market is expected to grow at a significant rate due to advancements in treatment, the development of innovative therapies, and increasing awareness among patients and healthcare providers.

Demand – Drivers and Limitations

The following are the drivers for the global chronic pancreatitis market:

Rising Prevalence of Chronic Pancreatitis and EPI: Increasing global incidence of chronic pancreatitis and associated exocrine pancreatic insufficiency (EPI) fuels sustained demand for enzyme replacement therapy, especially in aging populations and regions with high alcohol consumption and lifestyle-related risk factors.
Strong Adoption of Pancreatic Enzyme Replacement Therapy (PERT): Multiple PERT brands with proven efficacy, established guidelines, and broad regulatory approvals across major markets underpin consistent revenue growth and treatment standardization.
Pipeline Innovation Beyond Supportive Care: Emerging therapies targeting pain, inflammation, and fibrosis (e.g., camostat, tocilizumab, stem cells) present long-term growth opportunities, shifting the market toward disease-modifying interventions.

The global chronic pancreatitis market is expected to face some limitations too, due to the following challenges:

Absence of Curative Therapies: No approved disease-modifying treatment exists for chronic pancreatitis, limiting market expansion to supportive care and preventing significant innovation-driven growth in the near term.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: This report helps organizations identify innovation opportunities by mapping the current therapy landscape in chronic pancreatitis. It highlights gaps in disease-modifying treatments, assesses the growth trajectory of pancreatic enzyme replacement therapies, and evaluates emerging assets. By understanding regulatory approvals, pipeline strength, and unmet needs, companies can align R&D priorities, optimize formulation strategies, and explore differentiated delivery methods to achieve competitive advantages in product innovation.

Key Market Players and Competition Synopsis

The competitive landscape of chronic pancreatitis is concentrated around pancrelipase-based enzyme therapies. With current competition limited to supportive enzymes, companies developing anti-inflammatory and antifibrotic interventions may gain a first-mover advantage in reshaping long-term chronic pancreatitis treatment.

Some of the prominent names established in this market are:

AbbVie Inc.
Ono Pharmaceutical Co., Ltd

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
Scope of Study
Research Methodology
1. Global Chronic Pancreatitis Market: Industry Outlook
1.1 Market Overview
1.2 Epidemiological Analysis
1.3 Clinical Trials
1.4 Regulatory Landscape / Compliance
1.5 Key Trends
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Restraints
1.6.4 Market Opportunities
2. Global Chronic Pancreatitis Market (By Region), $Million, 2023-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Chronic Pancreatitis Market, by Country
2.1.2.1.1 U.S.
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Chronic Pancreatitis Market, by Country
2.2.2.1.1 U.K.
2.2.2.1.2 Germany
2.2.2.1.3 France
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Chronic Pancreatitis Market, by Country
2.3.2.1.1 Japan
3. Global Chronic Pancreatitis Market - Competitive Landscape and Company Profiles
3.1 Key Developments and Strategies
3.1.1 Funding Activities
3.1.2 Mergers and Acquisitions
3.1.3 Regulatory Approvals
3.1.4 Partnerships, Collaborations and Business Expansions
3.2 Company Profiles
3.2.1 AbbVie Inc.
3.2.1.1 Company Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers/End Users
3.2.1.4 Analyst View
3.2.2 Ono Pharmaceutical Co., Ltd
3.2.2.1 Company Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers/End Users
3.2.2.4 Analyst View
3.2.3 Others
4. Research Methodology
List of Figures
Figure: Chronic Pancreatitis Market (by Scenario), $Million, 2024, 2030, and 2035
Figure: Global Chronic Pancreatitis Market, 2024 and 2035
Figure: Global Chronic Pancreatitis Market Key Trends, Impact Analysis, 2023-2035
Figure: North America Chronic Pancreatitis Market, $Million, 2023-2035
Figure: Europe Chronic Pancreatitis Market, $Million, 2023-2035
Figure: Asia-Pacific Chronic Pancreatitis Market, $Million, 2023-2035
List of Tables
Table: Market Snapshot
Table: Market Dynamics
Table: Global Chronic Pancreatitis Market (by Region), $Million, 2023-2035

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us